RAC 3.01% $1.45 race oncology ltd

ASH2023 - Sheba 2.0, page-65

  1. 955 Posts.
    lightbulb Created with Sketch. 236
    * reply to @Titans19
    Don't think they're saying it wouldn't be used in the current combo again. Just that it could indicate positive synergy with other SOC drugs in different classes, the more widespread it can be used the better right?

    Ventoclax has been mentioned as showing synergy in previous preclinical work, and in a past life on HC Dr T said it was the combination he'd most list to see. Also the combination in one of the AML combo trails in the strategy update being reviewed.
    Last edited by cas33VFL: 03/11/23
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.